New enzyme target could lead to breakthrough therapies for Lyme disease
- Researchers have identified an enzyme called BbLDH as a potential target for new therapies against Lyme disease and possibly other tick-borne diseases, according to a study published in mBio.
- Researchers discovered that an enzyme, BbLDH, is essential for the growth and infectivity of Borrelia burgdorferi, the pathogen causing Lyme disease, enabling potential new treatments for this illness and others, as reported by Chunhao Li.
- Virginia Commonwealth University researchers found that BbLDH is essential for the growth and infectivity of Borrelia burgdorferi in vitro and in vivo.
- The Maine CDC reported a record 3,218 Lyme disease cases in 2024, with 291 cases logged so far in 2025, highlighting the need for public awareness about tick bite prevention.
Insights by Ground AI
Does this summary seem wrong?
17 Articles
17 Articles
All
Left
1
Center
8
Right

+2 Reposted by 2 other sources
Tick activity surges in Maine with arrival of warmer weather
If you spot a tick right now, it's most likely an adult deer tick, which can transmit Lyme disease.
·Portland, United States
Read Full ArticleCoverage Details
Total News Sources17
Leaning Left1Leaning Right0Center8Last UpdatedBias Distribution89% Center
Bias Distribution
- 89% of the sources are Center
89% Center
11%
C 89%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage